RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study.

Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study.

Add to Collection
2011 Dec RCTs Fist_Author_Year_PM

Full Author : ['Nowicki, M', 'Rychlik, I', 'Haller, H', 'Warren, M', 'Suchower, L', 'Gause-Nilsson, I', 'Schutzer, K-M']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2011
Cited by : Not Available

OBJECTIVE: Therapeutic options are limited for diabetes patients with renal disease. This report presents 52-week results from a study assessing the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus (T2DM) and renal im.....

Keywords : ["type diabetes mellitus", "randomised control efficacy", "dipeptidyl inhibitor saxagliptin", "safety study", "renal impairment", "longterm treatment", "patient"]